Flow resistance modulated aerosolized active agent delivery
First Claim
1. A device for controlling the delivery of an aerosolized active agent to the lungs of a human patient, said device comprising a valve that provides a high flow resistance of at least 0.4 (cm H2O)1/2/SLM in the inhalation direction at the onset of the patient'"'"'s inhalation and that subsequently opens during the inhalation to provide a lower flow resistance, wherein the lower flow resistance allows for a higher flow rate through the device.
4 Assignments
0 Petitions
Accused Products
Abstract
The present invention is directed to methods and devices for delivering an active agent formulation to the lung of a human patient. The active agent formulation may be in dry powder form, it may be nebulized, or it may be in admixture with a propellant. The active agent formulation is delivered to a patient at a low inspiratory flow rate for an initial period of time to increase bioavailability of the active agent.
-
Citations
16 Claims
- 1. A device for controlling the delivery of an aerosolized active agent to the lungs of a human patient, said device comprising a valve that provides a high flow resistance of at least 0.4 (cm H2O)1/2/SLM in the inhalation direction at the onset of the patient'"'"'s inhalation and that subsequently opens during the inhalation to provide a lower flow resistance, wherein the lower flow resistance allows for a higher flow rate through the device.
- 8. A device for controlling the delivery of an aerosolized active agent to the lungs of a human patient, said device comprising a valve that provides a high flow resistance in the inhalation direction at the onset of the patient'"'"'s inhalation and which corresponds to a flow rate of about 15 liters per minute or less and that subsequently opens during the inhalation to provide a lower flow resistance which corresponds to a higher flow rate.
- 12. A device for controlling the delivery of an aerosolized active agent to the lungs of a human patient, said device comprising a valve that is adapted to provide a first flow resistance in the inhalation direction at the onset of the patient'"'"'s inhalation and that subsequently opens during the inhalation to provide a second flow resistance, the second flow resistance being less than the first flow resistance, wherein the second flow resistance allows for a higher flow rate.
Specification